期刊文献+

载转化生长因子-β_1壳聚糖-聚己内酯微球制备及其可控释放性质研究

Preparation of Chitosan-Polycaprolactone Microspheres for Controllable Delivery of Transforming Growth Factor-Beta1
原文传递
导出
摘要 目的:制备载转化生长因子β1(TGF-β1)的壳聚糖-聚己内酯微球并研究其体外缓释行为。方法:以三聚磷酸钠为交联剂,利用水/油乳液方法制备载TGF-β1因子的壳聚糖-聚己内酯微球。利用酶联免疫吸附方法(ELISA)检测壳聚糖-聚己内酯微球的体外缓释行为。结果:在目前制备条件下,壳聚糖-聚己内酯微球具有好的形态,平均粒径可有效控制在10-20μm范围内。壳聚糖-聚己内酯中的聚己内酯含量能有效控制微球的初始释放和随后的缓释行为。优化获得的壳聚糖-聚己内酯微球能够以不同的速率控制TGF-β1持续释放超过4周。结论:载TGF-β1因子壳聚糖-聚己内酯微球的制备工艺稳定和可控,其初始释放和持续缓释行为可以由壳聚糖-聚己内酯中聚己内酯的含量有效调控。 Objective: TGF-β1-loaded chitosan-polycaprolctone(CH-PCL) microspheres were prepared and their TGF-β1 release behavior was examined.Methods: TGF-β1-loaded CH-PCL microspheres were produced by an emulsion method using sodium tripolyphosphate as a crosslinker.The release patterns of TGF-β1 inside the microspheres were investigated using enzyme-linked immunosorbent assay(ELISA).Results: CH-PCL microspheres showed a good sphericity with various average diameters changing between 10 and 20 μm.The percentage of PCL inside CH-PCLs could effectively control the release behavior of the microspheres at the early stage as well as the follow-up duration.Some optimal microspheres were capable of administrating the release of TGF-β1 in a well-controlled manner over four weeks with greatly reduced initial burst.Conclusion: The presented method for preparing TGF-β1-loaded CH-PCL microspheres was controllable and stable,and meanwhile,the release behavior of the microspheres could also be effectively modulated by the PCL content in CH-PCL.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2012年第4期457-461,共5页 Medical Journal of Wuhan University
关键词 壳聚糖-聚己内酯共聚物 微球 转化生长因子Β1 可控释放 Chitosan-Polycaprolctone Copolymer Microsphere Transforming Growth Factor-β1 Controllable Delivery
  • 相关文献

参考文献10

二级参考文献45

  • 1范宏斌,胡蕴玉,吴红,李旭升,王军,白建萍,吕荣.转化生长因子明胶微球制备及体外缓释研究[J].中国矫形外科杂志,2005,13(3):208-211. 被引量:11
  • 2卫克文,樊明文,吴补领.GbpB-壳聚糖纳米颗粒系统的构建及其经鼻免疫大鼠的实验研究[J].口腔医学研究,2005,21(5):488-491. 被引量:3
  • 3司晓辉,杨连君,金岩,杨连甲.转化生长因子β的提取、纯化及其促进骨生长作用的实验观察[J].细胞与分子免疫学杂志,1997,13(1):5-8. 被引量:6
  • 4Nimni ME. Polypeptide growth factors: targeted delivery systems [J]. Biomaterials,1997,18(18):1201-1225.
  • 5Groenveld MC, Evert V, Beertsen W, et al. Expression of extracellular matrix proteins in human periodontal ligament cells during mineralization in vitro [J]. Dent Res,1993,72:13dd-1350.
  • 6Nagatomo K, Komaki M, Sekiya I, et al. Stem cell properties of human periodontal ligament cells [J]. Periodontal Res,2006,41(4):303-310.
  • 7vander Berg WB, Vander Kraan PM, Scharstuhl A, et al. Growth factors and cartilage repair [J]. Clin Orthop Relat Res,2001,391:244-250.
  • 8Gao J, Symons AL, Bartold PM. Expression of transforming growth factor-beta receptors types Ⅱ and Ⅲ with in various cells in the rat periodent [J]. Periodontal Res,1999,34(2):113-122.
  • 9Esposito E, Pastesini C. Controlled release of 1-D-arabinofuranosyl-cytosine from hydrophilic gelatin microsphere: in vitro studies [J].Inter J Pharm,1995,17: 151-158.
  • 10Newman KD, Mcbumey MW. Poly(D, L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells [J]. Biomaterials, 2004,25(26):5763-5771.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部